Bottom line
MEDI vs FSPHX: the short answer
MEDI (Harbor Health Care ETF) and FSPHX (Health Care Portfolio) are both etfs.
But FSPHX is far broader, holding 152 positions to 44 for MEDI, so beyond the top names it adds exposure MEDI doesn't have.
FSPHX is cheaper at 0.62% vs 0.8% — a difference of $18 a year per $10,000 invested.
Over one year, MEDI returned +27.1% vs +14.4% for FSPHX (reporting dates differ).
Updated Nov 19, 2026
MEDI vs FSPHX side by side
| MEDI | FSPHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Oakmark (Harris) | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 0.62% |
| Annual cost per $10k | $80 | $62 |
| 10-yr cost on $10k (prospectus) | $990 | $774 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +27.1% | +14.4% |
| 5-yr return (annualized) | — | +4.0% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | +14.4% | +22.2% |
| Worst quarter | −10.9% | −15.0% |
| Net assets (fund) | $41.2M | $5.8B |
| Number of holdings | 44 | 152 |
| Portfolio turnover | 167% | 69% |
| Returns as of | Dec 31, 2025 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MEDI | FSPHX | Difference |
|---|---|---|---|
| 2025 | +27.1% | +14.4% | +12.7% |
| 2024 | +0.5% | +4.9% | −4.4% |
| 2023 | +24.8% | +4.1% | +20.7% |
Source: Fund prospectus bar charts
Holdings overlap
11 of MEDI's top 25 holdings also appear in FSPHX's top 25.
| Holding | MEDI | FSPHX |
|---|---|---|
| Eli Lilly & Co | 20.78% | 8.03% |
| Ascendis Pharma A/S | 13.61% | 2.17% |
| Gilead Sciences Inc | 5.10% | 2.21% |
| AbbVie Inc | 3.09% | 2.03% |
| Cencora Inc | 2.75% | 1.14% |
| Merck & Co Inc | 2.47% | 1.60% |
| Boston Scientific Corp | 2.40% | 2.17% |
| Natera Inc | 2.26% | 1.27% |
| Argenx SE | 2.07% | 1.56% |
| Danaher Corp | 1.73% | 6.89% |
| UnitedHealth Group Inc | 1.39% | 3.49% |
Source: SEC Form N-PORT
MEDI top 10
- Eli Lilly & Co — 20.78%
- Ascendis Pharma A/S — 13.61%
- Gilead Sciences Inc — 5.10%
- Rhythm Pharmaceuticals Inc — 4.02%
- AbbVie Inc — 3.09%
- Intuitive Surgical Inc — 2.83%
- Cencora Inc — 2.75%
- Revolution Medicines Inc — 2.54%
- Insmed Inc — 2.52%
- Merck & Co Inc — 2.47%
FSPHX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
FAQ
What is the difference between MEDI and FSPHX?
Which is cheaper, MEDI or FSPHX?
Should I own both MEDI and FSPHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.